序号 |
标题 |
次数 |
作者 |
发布时间 |
74116 |
氨基-二聚乙二醇-VG-N-双(一聚乙二醇-叠氮),Amino-PEG2-VG-N-Bis(PEG1-azide) |
68 |
kx |
2024-12-19 |
74117 |
DOTA-NHS ester,羟基琥珀酰亚胺-四氮杂环十二烷四乙酸(CAS号:170908-81-3) |
95 |
WYQ |
2024-12-19 |
74118 |
Maleimido-mono-amide-DOTA(CAS号:1006711-90-5) |
152 |
WYQ |
2024-12-19 |
74119 |
cas:2055041-40-0,Azido-PEG1-Val-Cit-PAB-OH,叠氮-一聚乙二醇-VAL-CIT-PAB-羟基 |
69 |
kx |
2024-12-19 |
74120 |
MB-VC-MGBA CAS号:932744-62-2 |
106 |
WYQ |
2024-12-19 |
74121 |
Anti-GPNMB-VC-MMAE-ADC抗体偶联药物 |
86 |
zyl |
2024-12-19 |
74122 |
MA-PEG8-VA-PAB-SG3199,硫醇反应SET™毒素 |
137 |
WYQ |
2024-12-19 |
74123 |
cas:1662687-83-3 , Mal-PEG2-Val-Cit-PABA,马来酰亚胺-二聚乙二醇-VAL-CIT-PABA |
78 |
kx |
2024-12-19 |
74124 |
Boc-Val-Ala-PAB cas:1884577-99-4 |
81 |
zyl |
2024-12-19 |
74125 |
perfluorophenyl 1-(cyclooct-2-ynyloxy)-2-oxo-6,9,12-trioxa-3-azapentadecan-15-oate |
71 |
wyh |
2024-12-19 |
74126 |
MA-PEG4-VA-PBD(CAS号:2259318-50-6) |
102 |
WYQ |
2024-12-19 |
74127 |
SPDP-Val-Cit-PAB-PNP-ADC抗体偶联药物 |
135 |
zyl |
2024-12-19 |
74128 |
cas:1438853-35-0,Mal-PEG3-Val-Cit-PAB-PNP,马来酰亚胺-三聚乙二醇-VAL-CIT-PAB-PNP 酯 |
71 |
kx |
2024-12-19 |
74129 |
Mc-vc-PABC-SP 141,一种用于抗体药物偶联物(ADC)合成的linker或连接臂 |
75 |
WYQ |
2024-12-19 |
74130 |
perfluorophenyl 1-(1,3-dioxoisoindolin-2-yloxy)-3,6,9,12-tetraoxapentadecan-15-oate |
104 |
wyh |
2024-12-19 |
74131 |
cas:2055041-37-5,Mal-PEG1-Val-Cit-PAB-OH,马来酰亚胺-一聚乙二醇-VAL-CIT-PAB-羟基 |
107 |
kx |
2024-12-19 |
74132 |
perfluorophenyl 15-(2,5-dioxo-2H-pyrrol-1(5H)-yl)-13-oxo-3,6,9-trioxa-12-azapentadecan-1-oate |
92 |
wyh |
2024-12-19 |
74133 |
MC-Val-Cit-PAB-PNP cas:159857-81-5 |
91 |
zyl |
2024-12-19 |
74134 |
NAMPT-linker(CAS号:2241019-57-6) |
77 |
WYQ |
2024-12-19 |
74135 |
cas:103848-61-9,6-Maleimidocaproic acid sulfo-NHS |
92 |
wyh |
2024-12-19 |
74136 |
cas:159857-80-4 ,MC-Val-Cit-PAB-OH, ADC(抗体偶联药物 ) |
99 |
kx |
2024-12-19 |
74137 |
Boc-Val-Cit cas:870487-08-4 |
125 |
zyl |
2024-12-19 |
74138 |
cas:663598-66-1,1-((4-((5-Nitropyridin-2-yl)disulfanyl)pentanoyl)oxy)-2,5-dioxopyrrolidine-3-sulfonic acid |
84 |
wyh |
2024-12-19 |
74139 |
cas:870487-10-8,Boc-Val-Cit-PAB-PNP,BOC-VAL-CIT-PAB-PNP 酯 |
88 |
kx |
2024-12-19 |
74140 |
cas:2353409-69-3 Mal-PEG8-Val-Cit-PAB-MMAE |
133 |
zyl |
2024-12-19 |
74141 |
cas:108852-90-0 Nemorubicin 奈莫柔比星 |
109 |
zyl |
2024-12-19 |
74142 |
cas:159858-22-7 , Fmoc-Val-Cit-PAB-OH,ADC(抗体偶联药物) |
72 |
kx |
2024-12-19 |
74143 |
cas:1626359-59-8 磺基-SPDB-DM4 |
80 |
zyl |
2024-12-19 |
74144 |
cas:870487-09-5,Boc-Val-Cit-PAB, ADC试剂 |
72 |
kx |
2024-12-19 |
74145 |
NH2-Glu-Gly-Cit-PAB-OH, ADC试剂 |
141 |
kx |
2024-12-19 |
74146 |
sulfo-SPDB-DGN462,用于提高化合物的水溶性和稳定性 |
128 |
WYQ |
2024-12-19 |
74147 |
Fmoc-Gly-Gly-Phe-Gly-OH, ADC试剂 |
104 |
kx |
2024-12-19 |
74148 |
1342211-31-7,MC-Val-Ala-OH,马来酰亚胺基己酰-L-缬氨酰-L-丙氨酸,ADC连接子多肽 |
131 |
kx |
2024-12-19 |
74149 |
MA-PEG4-VC-PAB-DMAE-PNU159682(CAS号:2259318-52-8) |
98 |
WYQ |
2024-12-19 |
74150 |
MC-vc-PAB-C6-a-amanitin,一种抗体药物偶联物(ADC) |
95 |
WYQ |
2024-12-19 |
74151 |
cas:690632-55-4,N-Succinimidyloxycarbonylpropyl Methanethiosulfonate |
62 |
wyh |
2024-12-19 |
74152 |
VC-MMAF(CAS号:863971-17-9) |
83 |
WYQ |
2024-12-19 |
74153 |
cas:159857-70-2 MC-Val-Cit-Doxorubicin-ADC抗体偶联药物 |
81 |
zyl |
2024-12-19 |
74154 |
2055024-62-7,NH2-PEG3-Val-Cit-PAB-OH, ADC试剂 |
83 |
kx |
2024-12-19 |
74155 |
cas:1834516-06-1 Fmoc-Ala-Ala-Asn-PABC-PNP |
95 |
zyl |
2024-12-19 |
74156 |
perfluorophenyl 1-(1,3-dioxoisoindolin-2-yloxy)-3,6,9,12-tetraoxapentadecan-15-oate |
99 |
wyh |
2024-12-19 |
74157 |
MC -Val-Cit, ADC试剂 |
127 |
kx |
2024-12-19 |
74158 |
cas:141534-26-1,2-(4-formylbenzamido)ethyl nitrate |
137 |
wyh |
2024-12-19 |
74159 |
cas:159857-81-5 Mc-Val-Cit-PABC-PNP |
96 |
zyl |
2024-12-19 |
74160 |
MC-PEG4-va-PAB-Exatecan, ADC试剂 |
140 |
kx |
2024-12-19 |